Devic disease;Maladie de Devic

Presse Medicale

Volumn 35, Issue 11 II, 2006, Pages 1703-1706

  Papeix, Caroline ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT; IMMUNOGLOBULIN M; IMMUNOSUPPRESSIVE AGENT;

ANTIBODY SPECIFICITY; CLINICAL FEATURE; COMPLEMENT DEPOSITION; HUMAN; IMMUNOGLOBULIN PRODUCING CELL; MYELOOPTIC NEUROPATHY; NEUROPATHOLOGY; REVIEW;

EID: 33750733933     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0755-4982(06)74884-9     Document Type: Review

References (19)

1. Devic E. Myélite subaiguë compliquée de névrite optique. Bull Med. 1894; 8: 1033-4.
2. Scolding N. Devic's disease and autoantibodies. Lancet neurol. 2005; 4: 136-7
3. Wingerchuk DM, Hogancamp WF, O'Brien PC, Weinshenker BG. The clinical course of neuromyelitis optica (Devic's syndrome). Neurology. 1999; 53: 1107-14.
4. Cabre P, Heinzlef O, Merle H, Buisson CG, Bera O, Bellance R et al. MS and neuromyelitis optica in Martinique (West French Indies). Neurology. 2001; 56: 507-14.
5. Misu T, Fujihara K, Nakashima I, Miyazawa I, Okita N, Takase S et al. Pure optic-spinal form of multiple sclerosis in Japan. Brain. 2002; 125: 2460-8.
6. Mandler RN, Davis LE, Jeffery DR, Kornfeld M. Devic's neuromyelitis optica: a clinicopathological study of 8 patients. Ann Neurol. 1993; 34: 162-8.
7. Lucchinetti CF, Mandler RN, McGavern D, Bruck W, Gleich G, Ransohoff RM et al. A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica. Brain. 2002; 125: 1450-61.
8. Papeix C LC, Moreau T, Tourbah A, Gout O. Spinal cord magnetic resonance characteristics in Devic's neuromyelitis optica. Multiple sclerosis. 2003: S110.
9. Deschamps R, Gout O, Fontaine B, Rigolet MH, Cabanis EA, Lyon-Caen O et al. Neuropathie optique inflammatoire aiguë: facteurs pronostiques cliniques et IRM. Rev Neurol. 2002; 158: 446-52.
10. Kupersmith MJ, Alban T, Zeiffer B, Lefton D. Contrast-enhanced MRI in acute optic neuritis: relationship to visual performance. Brain. 2002; 125: 812-22.
11. de Seze J, Stojkovic T, Ferriby D, Gauvrit JY, Montagne C, Mounier-Vehier F et al. Devic's neuromyelitis optica: clinical, laboratory, MRI and outcome profile. J Neurol Sci. 2002; 197: 57-61.
12. Filippi M, Rocca MA, Moiola L, Martinelli V, Ghezzi A, Capra R. et al. MRI and magnetization transfer imaging changes in the brain and cervical cord of patients with Devic's neuromyelitis optica. Neurology. 1999; 53: 1705-10.
13. O'Riordan JI, Gallagher HL, Thompson AJ, Howard RS, Kingsley DP, Thompson EJ et al. Clinical, CSF, and MRI findings in Devic's neuromyelitis optica. J Neurol Neurosurg Psychiatry. 1996; 60: 382-7.
14. Lennon VA, Kryzer TJ, Pittock SJ, Verkman AS, Hinson SR. IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J Exp Med. 2005; 202: 473-77.
15. Lennon VA, Wingerchuk DM, Kryzer TJ, Pittock SJ, Lucchinetti CF, Fujihara K et al. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet. 2004; 364: 2106-12.
16. Weinshenker BG, Wingerchuk DM, Linbo L, Lennon V. NMO-IgG predicts relapse in patients with longitudinally extensive "idiopathic" transverse myelitis. Neurology. 2005; 64: A 128.
17. Mandler RN, Ahmed W, Dencoff JE. Devic's neuromyelitis optica: a prospective study of seven patients treated with prednisone and azathioprine. Neurology. 1998; 51: 1219-20.
18. Cree BA, Lamb S, Morgan K, Chen A, Waubant E, Genain C. An open label study of the effects of rituximab in neuromyelitis optica. Neurology. 2005; 64: 1270-2.
19. Papeix C, De Seze J, Pierrot-Deseilligny C, Tourbah A, Lebrun C, Moreau T et al. French therapeutic experience of Devic's diseaese: a retrospective study of 33 cases. Neurology. 2005; 64: A328.